SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DI IASIO, Maria Grazia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.574
EU - Europa 571
AS - Asia 354
OC - Oceania 1
SA - Sud America 1
Totale 3.501
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.573
CN - Cina 217
UA - Ucraina 179
DE - Germania 103
TR - Turchia 99
GB - Regno Unito 82
IT - Italia 78
SE - Svezia 48
FI - Finlandia 40
SG - Singapore 27
NL - Olanda 11
BE - Belgio 10
FR - Francia 8
RU - Federazione Russa 5
IR - Iran 4
CZ - Repubblica Ceca 3
ID - Indonesia 2
VN - Vietnam 2
AU - Australia 1
BR - Brasile 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
IN - India 1
JP - Giappone 1
MD - Moldavia 1
MX - Messico 1
PL - Polonia 1
Totale 3.501
Salva come PNG Salva come JPEG
Città #
Fairfield 408
Woodbridge 385
Houston 226
Jacksonville 199
Ashburn 180
Chandler 169
Ann Arbor 140
Seattle 134
Wilmington 121
Cambridge 104
Izmir 66
Beijing 52
Nanjing 47
Princeton 40
San Diego 39
New York 32
Ferrara 31
Boardman 28
Shanghai 19
Falls Church 18
Singapore 18
Nanchang 16
Milan 15
Changsha 12
Shenyang 12
Hebei 11
San Mateo 11
Tianjin 11
Dearborn 10
Brussels 9
Jiaxing 7
Norwalk 7
Orange 7
Zhengzhou 7
Dronten 6
Jinan 6
Los Angeles 6
Verona 6
Washington 6
Auburn Hills 5
Bremen 5
Kunming 5
Leawood 5
London 5
Mountain View 5
Augusta 4
Helsinki 4
Ardabil 3
Brno 3
Haikou 3
Monmouth Junction 3
Padova 3
Philadelphia 3
Des Moines 2
Dong Ket 2
Düsseldorf 2
Indiana 2
Jakarta 2
Ningbo 2
Prescot 2
Redmond 2
Tappahannock 2
Acton 1
Addison 1
Atlanta 1
Changchun 1
Chisinau 1
Edinburgh 1
Frankfurt am Main 1
Fuzhou 1
Hangzhou 1
Islington 1
Jinhua 1
Kilburn 1
Lanzhou 1
Logan 1
Marienheide 1
Mexico City 1
Monselice 1
Munich 1
New Bedfont 1
Paris 1
Redwood City 1
Rouen 1
Saint Petersburg 1
San Francisco 1
Secaucus 1
Stockholm 1
Taiyuan 1
Taizhou 1
Tel Aviv 1
Tokyo 1
Veranopolis 1
Wandsworth 1
Wisconsin Rapids 1
Totale 2.728
Salva come PNG Salva come JPEG
Nome #
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 138
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 125
Nutlin-3 upregulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feed-back anti-apoptotic mechanism 124
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 119
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 111
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 108
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 105
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 105
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 104
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 104
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 103
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 101
The non-genotoxic activator of the p53 pathway Nutlin-3 shifts the balance between E2F7 and E2F1 transcription factors in leukemic cells 101
null 100
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 99
null 98
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 98
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 98
null 98
null 97
Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin 96
The MDM2 inhibitor Nutlins as an innovative therapeutic tool for the treatment of haematological malignancies 95
Reduced expression of cell cycle-associated genes in B lymphocytes purified from the peripheral blood of early-stage B chronic lymphocytic leukaemia patients 93
TNFRSF11B (tumor necrosis factor receptor superfamily, member 11b) 92
SOCS1 is significantly up-regulated in Nutlin-3-treated p53 wild-type B chronic lymphocytic leukemia (BCLL) samples and shows an inverse correlation with miR-155 90
Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region 90
null 89
null 83
Activation of the p53 pathway down-regulates the osteoprotegerin (OPG) expression and release by vascular endothelial cells. 78
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 76
null 69
Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms 68
Exposure of B cell chronic lymphocytic leukemia (B-CLL) cells to Nutlin-3 induces a characteristic gene expression profile, which correlates with Nutlin-3-mediated cytotoxicity 62
TNFSF10 (tumor necrosis factor Ligand) surfamily,member 10) 55
null 55
Risk of venous thromboembolism and stroke associated with oral contraceptives. Role of congenital thrombophilias 50
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 32
C reactive protein down-regulates TNF-related apoptosis inducing ligand expression in human peripheral monocytes via an Egr-1 dependent pathway. 25
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 23
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women 20
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 18
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes 15
Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. 14
Nutlin-3 downregulates the expression of the Oncogene TCL1 in primary B Chronic Lymphocytic Leukemic cells. 11
Totale 3.535
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.178
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020866 124 30 33 135 60 95 80 93 70 80 53 13
2020/2021535 47 64 14 83 17 51 18 54 10 59 89 29
2021/2022449 12 60 27 23 22 20 33 22 12 27 52 139
2022/2023398 41 20 20 41 66 57 11 32 54 7 28 21
2023/2024149 23 13 7 3 6 29 8 17 1 4 2 36
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 3.535